SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study-Reference-Cited by-同舟云学术

SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study

Published:2021-07 Issue:7 Volume:3 Page:e481-e488
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Saadoun David,Vieira Matheus,Vautier Mathieu,Baraliakos Xenofon,Andreica Ioana,da Silva José A P,Sousa Marlene,Luis Mariana,Khmelinskii Nikita,Gracía José María Alvaro,Castrejon Isabel,Gonzalez Juan Carlos Nieto,Scirè Carlo Alberto,Silvagni Ettore,Bortoluzzi Alessandra,Penn Henry,Hamdulay Shahir,Machado Pedro M,Fautrel Bruno,Cacoub Patrice,Resche-Rigon Matthieu,Gossec Laure

Funder

Amgen Inc

Eli Lilly and Co

Pfizer Ltd

Sanofi Genzyme

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference27 articles.

1. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study;Pollán;Lancet,2020

2. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease;Hayter;Autoimmun Rev,2012